Beam Therapeutics Inc (BEAM)
21.62
-1.12
(-4.93%)
USD |
NASDAQ |
Apr 25, 16:00
21.62
0.00 (0.00%)
After-Hours: 20:00
Beam Therapeutics Total Assets (Quarterly): 1.460B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.460B |
September 30, 2023 | 1.291B |
June 30, 2023 | 1.354B |
March 31, 2023 | 1.332B |
December 31, 2022 | 1.342B |
September 30, 2022 | 1.350B |
June 30, 2022 | 1.418B |
March 31, 2022 | 1.453B |
December 31, 2021 | 1.474B |
September 30, 2021 | 1.157B |
Date | Value |
---|---|
June 30, 2021 | 893.08M |
March 31, 2021 | 693.24M |
December 31, 2020 | 451.68M |
September 30, 2020 | 278.27M |
June 30, 2020 | 299.98M |
March 31, 2020 | 322.64M |
December 31, 2019 | 156.10M |
September 30, 2019 | 170.55M |
June 30, 2019 | 180.55M |
December 31, 2018 | 167.01M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
156.10M
Minimum
Dec 2019
1.474B
Maximum
Dec 2021
898.81M
Average
1.157B
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
Eli Lilly and Co | 64.01B |
Moderna Inc | 18.43B |
Pfizer Inc | 226.50B |
Editas Medicine Inc | 499.15M |
Intellia Therapeutics Inc | 1.301B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 478.38M |
Shareholders Equity (Quarterly) | 981.33M |
Current Ratio | 5.891 |